Scientists at Scripps Research have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide.
Described in the journal ACS Infectious Diseases, the new, non-invasive test may provide an inexpensive method of determining in real time whether a person has an infection, which would give public health officials and doctors critical information for tracking outbreaks and treating current infections.
“River blindness affects individuals both in Africa and Latin America, and because many of these endemic regions are difficult to access, what is needed in the field is an inexpensive point-of-care means to monitor the disease,” says Kim Janda, PhD, the Ely R. Callaway Jr. Professor of Chemistry and member of the Skaggs Institute for Chemical Biology at Scripps Research.
River blindness is a filarial disease, like elephantiasis, and occurs when the parasitic worm Onchocerca volvulus takes up residence in the skin. Adult worms pump out babies (microfilaria) at an alarming rate, which are ultimately re-spread by blackfly bites. The microfilariae can migrate to the eye and die, releasing toxins and causing inflammation. People with the disease will slowly go blind without medical intervention.
Janda says onchocerciasis monitoring and evaluation are especially necessary steps for people leading elimination efforts. To know if these efforts are working, doctors need to be able to show when disease transmission has been interrupted. The current gold standard for detecting the parasitic worms is a “skin snip” biopsy. However, snips are generally insensitive indicators of infection, and the sensitivity of the skin snip decreases as the density of microfilaria in the skin decreases. Other tests cannot distinguish between past and current infections.
Currently, onchocerciasis elimination programs rely primarily on mass drug administration of the therapy Ivermectin to suppress and eventually eliminate transmission of Onchocerca volvulus. Yet, without a means to evaluate if an infection is ongoing, it’s hard to assess if prevention efforts are working—and if it’s safe for people to stop taking medication.
The new lateral flow assay took over 10 years to develop, but it is now ready for manufacturing and testing in the field. The key to the assay’s success was in the making of designer antibodies to detect a unique biomarker that only shows up when a human host has metabolized a worm neurotransmitter called tyramine. Humans then secrete this biomarker in urine.
A negative on the “dipstick” test shows a colored line in the test. Got the parasite? The test would show no lines.
Unlike the skin snip biopsy, Janda says this non-invasive test is the first to use a metabolite produced by adult worms. Moreover, the dipstick’s inexpensive design, coupled with smartphone apps, would offer automatic image processing, which ultimately could translate to address critical gaps in the surveillance and treatment of river blindness.
The Latest on: River blindness
via Google News
The Latest on: River blindness
- USF plays pivotal role in eradication of river blindness on September 17, 2018 at 9:23 pm
In life, some people are faced with heartbreaking problems they’re powerless to solve. Other times, that tragedy turns into triumph when there is an opportunity for positive change. Thomas Unnasch emb... […]
- First gene therapy to cure inherited human disease receives Champalimaud Vision Award on September 4, 2018 at 10:28 am
In 2011 the prize was awarded to APOC (the African Programme for Onchocerciasis Control), for a transcontinental effort to eliminate river-blindness, a blinding tropical disease. In 2013 there were fo... […]
- After an epic research journey, an inexpensive, practical test for river blindness on August 28, 2018 at 9:05 am
A practical test for river blindness, a parasitic tropical disease that affects more than 18 million people, and puts 120 million at risk, has been developed by a Scripps Research scientist. Unlike ex... […]
- New urine test detects cause of river blindness on August 27, 2018 at 9:08 pm
Scientists have developed a new urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwi... […]
- New urine test detects cause of river blindness on August 27, 2018 at 8:44 pm
The new, non-invasive test may provide an inexpensive method of determining in real time whether a person has an infection. Representational Image. (Photo: Pixabay) Washington: Scientists have develop... […]
- New urine dipstick test detects cause of disease that blinds millions on August 27, 2018 at 8:06 pm
Scientists have developed a urine diagnostic to detect the parasitic worms that cause river blindness, also called onchocerciasis, a tropical disease that afflicts 18 to 120 million people worldwide. ... […]
- Scientists developed new urine test detect that cause river blindness on August 27, 2018 at 5:00 pm
The new, non-invasive test may provide an inexpensive method of determining in real time whether a person has an infection, which would give public health officials and doctors critical information fo... […]
- FDA approves drug to treat river blindness developed by Australian organisation on August 23, 2018 at 12:33 am
A new drug, developed by Australian not-for-profit Medicines Development for Global Health, has been approved by the Food and Drug Administration in the United States. The drug, moxidectin, could help ... […]
- First new treatment for river blindness approved by U.S. FDA in 20 years on June 25, 2018 at 5:37 pm
The United States Food and Drug Administration (FDA) has approved moxidectin as the first new treatment for river blindness in 20 years, adding new ammunition to the fight to eliminate this disabling ... […]
via Bing News